H.B. Fuller Company
General ticker "FUL" information:
- Sector: Materials
- Industry: Chemicals - Specialty
- Capitalization: $3.3B (TTM average)
H.B. Fuller Company follows the US Stock Market performance with the rate: 28.9%.
Estimated limits based on current volatility of 1.2%: low 56.83$, high 58.18$
Factors to consider:
- Company pays dividends (quarterly): last record date 2026-04-30, amount 0.24$ (Y1.69%)
- Total employees count: 7100 (-5.3%) as of 2025
- China accounted for 12.3% of revenue in the fiscal year ended 2024-11-30
- US accounted for 45.5% of revenue in the fiscal year ended 2024-11-30
- Top business risk factors: Raw material costs, Cybersecurity threats, Market competition, Regulatory and compliance, Currency fluctuations
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-11-29 to 2027-11-29
- 2025-11-29 to 2026-11-29 estimated range: [50.09$, 70.54$]
- 2026-11-29 to 2027-11-29 estimated range: [54.07$, 75.53$]
Financial Metrics affecting the FUL estimates:
- Negative: with PPE of 13.4 at the end of fiscal year the price was very high
- Positive: 6.62 < Operating cash flow per share per price, % of 8.46
- Positive: -5.34 < Operating profit margin, % of 6.46
- Positive: 1.77 < Return on assets ratio (scaled to [-100,100]) of 2.85
- Positive: -0.03 < Industry operating cash flow per share per price (median), % of 4.96
- Negative: Investing cash flow per share per price, % of -7.46 <= -4.39
- Positive: 19.19 < Shareholder equity ratio, % of 38.65 <= 42.57
Short-term FUL quotes
Long-term FUL plot with estimates
Financial data
| YTD | 2023-12-02 | 2024-11-30 | 2025-11-29 |
|---|---|---|---|
| Operating Revenue | $3,510.93MM | $3,403.18MM | $3,333.94MM |
| Operating Expenses | $3,131.45MM | $3,220.52MM | $3,118.52MM |
| Operating Income | $379.49MM | $182.66MM | $215.42MM |
| Non-Operating Income | $-140.97MM | $0.00MM | $0.00MM |
| Interest Expense | $134.60MM | $133.12MM | $133.35MM |
| R&D Expense | $48.64MM | $49.56MM | $0.00MM |
| Income(Loss) | $238.52MM | $182.66MM | $215.42MM |
| Taxes | $93.53MM | $56.38MM | $67.13MM |
| Other Income(Loss) | $4.36MM | $4.11MM | $3.78MM |
| Net Income(Loss)* | $144.91MM | $130.26MM | $151.97MM |
| Stockholders Equity | $1,755.20MM | $1,828.66MM | $2,003.22MM |
| Inventory | $442.04MM | $467.50MM | $471.96MM |
| Assets | $4,723.57MM | $4,933.24MM | $5,182.71MM |
| Operating Cash Flow | $378.40MM | $302.44MM | $263.49MM |
| Capital expenditure | $119.14MM | $139.24MM | $142.28MM |
| Investing Cash Flow | $-319.20MM | $-407.08MM | $-232.25MM |
| Financing Cash Flow | $35.14MM | $112.09MM | $-107.90MM |
| Earnings Per Share** | $2.67 | $2.37 | $2.78 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.